source
- Opinion: Marty Makary misunderstood something fundamental about the FDA“The norm-shattering masks a more fundamental misunderstanding of how administrative power can bring about lasting change,” writes Joshua Sharfstein.STAT · 2mo ago↗ source
- Dr Croll on Radiographic Size Change vs irRVT After Neoadjuvant Therapy in RCCBenjamin Croll, MD, discusses findings from a study of the correlation between radiographic response and pathologic response in RCC.onclive · 2mo ago↗ source
- FDA Approves T-DXd for Early-Stage HER2+ Breast CancerThe FDA approved trastuzumab deruxtecan for the adjuvant and neoadjuvant treatment of select early-stage HER2-positive breast cancer.onclive · 2mo ago↗ source